Heparin Market Revenue 2025 to 2034
Heparin Market Revenue 2025 to 2034
Heparin Market (By Type: Low Molecular Weight Heparin, Ultra-low Molecular Weight Heparin, Unfractionated Heparin, By Route of Administration, Intravenous, Subcutaneous; By Packaging: Glass, Plastic, By Container: Bottles, Bags, Vials, Others; By Therapeutics: Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others; By Treatment: Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others; By Availability: Raw, Processed; By Application: Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Others; By Source: Bovine, Porcine; By Ingredients: Sodium, Calcium, Others; By Strength: 10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others; By End Use: Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others; By Distribution Channel: Hospital Pharmacy, Retail Pharmacy and Drug Store, Online Pharmacy, Others) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 6.36
Forecast Year, 2034
USD 10.21
CAGR, 2025 - 2034
5.37%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global heparin market reached USD 6.36 billion in 2025 and is expected to grow steadily to approximately USD 10.21 billion by 2034, driven by rising cardiovascular disorders, increasing surgical procedures, and expanding anticoagulant applications, at a CAGR of 5.37%.
Heparin Market Size Analysis
Heparin Market Size By Type 2025 to 2034 (USD Billion)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Low Molecular Weight Heparin | 3.50 | 3.68 | 3.87 | 4.07 | 4.28 | 4.50 | 4.73 | 4.98 | 5.24 | 5.51 |
| Ultra-low Molecular Weight Heparin | 0.95 | 1.00 | 1.06 | 1.12 | 1.18 | 1.24 | 1.30 | 1.38 | 1.45 | 1.53 |
| Unfractionated Heparin | 1.91 | 2.02 | 2.13 | 2.25 | 2.38 | 2.52 | 2.66 | 2.82 | 2.98 | 3.15 |
Heparin Market Size By Route of Administration 2025 to 2034 (USD Billion)
| Route of Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Intravenous | 2.86 | 3.01 | 3.16 | 3.33 | 3.50 | 3.68 | 3.86 | 4.06 | 4.27 | 4.49 |
| Subcutaneous | 3.50 | 3.69 | 3.90 | 4.11 | 4.34 | 4.58 | 4.84 | 5.11 | 5.39 | 5.69 |
Heparin Market Size By Packaging 2025 to 2034 (USD Billion)
| Packaging | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Glass | 4.13 | 4.35 | 4.57 | 4.81 | 5.06 | 5.33 | 5.60 | 5.90 | 6.20 | 6.53 |
| Plastic | 2.23 | 2.35 | 2.49 | 2.63 | 2.78 | 2.93 | 3.10 | 3.27 | 3.46 | 3.65 |
Heparin Market Size By Container 2025 to 2034 (USD Billion)
| Container | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bottles | 1.91 | 2.00 | 2.10 | 2.21 | 2.32 | 2.44 | 2.56 | 2.69 | 2.82 | 2.96 |
| Bags | 1.27 | 1.34 | 1.41 | 1.48 | 1.56 | 1.64 | 1.72 | 1.81 | 1.91 | 2.01 |
| Vials | 2.54 | 2.68 | 2.83 | 2.98 | 3.15 | 3.32 | 3.50 | 3.69 | 3.89 | 4.10 |
| Others | 0.64 | 0.68 | 0.72 | 0.77 | 0.82 | 0.87 | 0.92 | 0.98 | 1.04 | 1.11 |
Heparin Market Size By Therapeutics 2025 to 2034 (USD Billion)
| Therapeutics | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | 2.23 | 2.34 | 2.46 | 2.58 | 2.71 | 2.85 | 2.99 | 3.15 | 3.30 | 3.47 |
| Respiratory | 0.64 | 0.67 | 0.70 | 0.73 | 0.77 | 0.80 | 0.84 | 0.88 | 0.92 | 0.96 |
| Oncology | 0.95 | 1.00 | 1.06 | 1.11 | 1.17 | 1.23 | 1.29 | 1.36 | 1.43 | 1.51 |
| Nephrology | 1.27 | 1.34 | 1.41 | 1.49 | 1.57 | 1.66 | 1.75 | 1.85 | 1.95 | 2.05 |
| CNS | 0.32 | 0.34 | 0.36 | 0.39 | 0.41 | 0.44 | 0.47 | 0.50 | 0.53 | 0.56 |
| Others | 0.95 | 1.01 | 1.07 | 1.14 | 1.21 | 1.28 | 1.36 | 1.44 | 1.53 | 1.62 |
Heparin Market Size By Treatment 2025 to 2034 (USD Billion)
| Treatment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Deep Vein Thrombosis | 2.54 | 2.67 | 2.81 | 2.95 | 3.10 | 3.26 | 3.43 | 3.60 | 3.79 | 3.98 |
| Pulmonary Embolism | 1.59 | 1.67 | 1.76 | 1.85 | 1.95 | 2.05 | 2.16 | 2.27 | 2.39 | 2.51 |
| Arterial Thromboembolism | 1.27 | 1.34 | 1.42 | 1.50 | 1.58 | 1.67 | 1.76 | 1.86 | 1.96 | 2.07 |
| Others | 0.95 | 1.01 | 1.07 | 1.14 | 1.21 | 1.28 | 1.36 | 1.44 | 1.53 | 1.62 |
Heparin Market Size By Availability 2025 to 2034 (USD Billion)
| Availability | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Raw | 1.91 | 2.00 | 2.10 | 2.21 | 2.32 | 2.44 | 2.56 | 2.69 | 2.82 | 2.96 |
| Processed | 4.45 | 4.70 | 4.96 | 5.23 | 5.52 | 5.82 | 6.14 | 6.48 | 6.84 | 7.22 |
Heparin Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Venous Thromboembolism | 2.23 | 2.34 | 2.46 | 2.58 | 2.71 | 2.85 | 2.99 | 3.15 | 3.30 | 3.47 |
| Atrial Fibrillation | 1.59 | 1.67 | 1.76 | 1.85 | 1.94 | 2.04 | 2.15 | 2.26 | 2.38 | 2.50 |
| Renal Impairment | 0.95 | 1.00 | 1.06 | 1.12 | 1.18 | 1.24 | 1.30 | 1.38 | 1.45 | 1.53 |
| Coronary Artery Disease | 0.95 | 1.01 | 1.07 | 1.13 | 1.19 | 1.26 | 1.33 | 1.41 | 1.49 | 1.57 |
| Others | 0.64 | 0.68 | 0.72 | 0.77 | 0.82 | 0.87 | 0.92 | 0.98 | 1.04 | 1.11 |
Heparin Market Size By Source 2025 to 2034 (USD Billion)
| Source | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bovine | 1.91 | 2.00 | 2.10 | 2.21 | 2.32 | 2.44 | 2.56 | 2.69 | 2.82 | 2.96 |
| Porcine | 4.45 | 4.70 | 4.96 | 5.23 | 5.52 | 5.82 | 6.14 | 6.48 | 6.84 | 7.22 |
Heparin Market Size By Ingredients 2025 to 2034 (USD Billion)
| Ingredients | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sodium | 3.82 | 4.01 | 4.22 | 4.44 | 4.67 | 4.91 | 5.17 | 5.44 | 5.72 | 6.02 |
| Calcium | 1.91 | 2.01 | 2.12 | 2.23 | 2.35 | 2.48 | 2.61 | 2.75 | 2.90 | 3.05 |
| Others | 0.64 | 0.68 | 0.72 | 0.77 | 0.82 | 0.87 | 0.92 | 0.98 | 1.04 | 1.11 |
Heparin Market Size By Strength 2025 to 2034 (USD Billion)
| Strength | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 Unit | 0.32 | 0.33 | 0.34 | 0.35 | 0.36 | 0.37 | 0.38 | 0.39 | 0.41 | 0.42 |
| 100 Unit | 0.64 | 0.67 | 0.70 | 0.73 | 0.76 | 0.80 | 0.84 | 0.87 | 0.91 | 0.96 |
| 1000 Unit | 0.95 | 1.00 | 1.05 | 1.11 | 1.17 | 1.23 | 1.29 | 1.35 | 1.42 | 1.50 |
| 5000 Unit | 1.91 | 2.01 | 2.12 | 2.23 | 2.35 | 2.48 | 2.61 | 2.75 | 2.90 | 3.05 |
| 10000 Unit | 1.27 | 1.34 | 1.42 | 1.50 | 1.58 | 1.67 | 1.76 | 1.86 | 1.96 | 2.07 |
| 25000 Unit | 0.95 | 1.01 | 1.07 | 1.13 | 1.20 | 1.27 | 1.34 | 1.42 | 1.50 | 1.59 |
| Others | 0.32 | 0.34 | 0.37 | 0.39 | 0.42 | 0.45 | 0.49 | 0.52 | 0.56 | 0.60 |
Heparin Market Size By End Use 2025 to 2034 (USD Billion)
| End Use | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 2.86 | 3.01 | 3.16 | 3.33 | 3.50 | 3.68 | 3.86 | 4.06 | 4.27 | 4.49 |
| Clinics | 1.27 | 1.34 | 1.40 | 1.48 | 1.55 | 1.63 | 1.71 | 1.80 | 1.89 | 1.99 |
| Homecare | 0.95 | 1.00 | 1.06 | 1.12 | 1.18 | 1.24 | 1.30 | 1.38 | 1.45 | 1.53 |
| Ambulatory Surgical Centres | 0.64 | 0.67 | 0.71 | 0.76 | 0.80 | 0.85 | 0.90 | 0.95 | 1.00 | 1.06 |
| Others | 0.64 | 0.68 | 0.72 | 0.77 | 0.82 | 0.87 | 0.92 | 0.98 | 1.04 | 1.11 |
Heparin Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 2.86 | 3.01 | 3.16 | 3.33 | 3.50 | 3.68 | 3.86 | 4.06 | 4.27 | 4.49 |
| Retail Pharmacy and Drug Store | 1.91 | 2.01 | 2.11 | 2.22 | 2.34 | 2.46 | 2.59 | 2.73 | 2.87 | 3.02 |
| Online Pharmacy | 0.95 | 1.01 | 1.06 | 1.12 | 1.19 | 1.25 | 1.32 | 1.40 | 1.47 | 1.56 |
| Others | 0.64 | 0.68 | 0.72 | 0.77 | 0.82 | 0.87 | 0.92 | 0.98 | 1.04 | 1.11 |
Heparin Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.23 | 2.34 | 2.46 | 2.58 | 2.71 | 2.85 | 2.99 | 3.15 | 3.30 | 3.47 |
| Europe | 1.59 | 1.67 | 1.76 | 1.85 | 1.94 | 2.04 | 2.15 | 2.26 | 2.38 | 2.50 |
| Asia Pacific | 1.60 | 1.68 | 1.76 | 1.86 | 1.96 | 2.06 | 2.17 | 2.29 | 2.42 | 2.54 |
| Latin America | 0.51 | 0.54 | 0.57 | 0.61 | 0.64 | 0.68 | 0.72 | 0.77 | 0.81 | 0.86 |
| Middle East and Africa | 0.45 | 0.48 | 0.51 | 0.54 | 0.58 | 0.62 | 0.66 | 0.71 | 0.75 | 0.80 |
Heparin Market Size to Surpass USD 10.21 Billion by 2034
The global heparin market size surpassed USD 6.36 billion in 2025 and is predicted to reach around USD 10.21 billion by 2034, registering a CAGR of 5.37%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
